Cell therapy plus cochlear implant for adults with hearing loss
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This trial tests whether a new cell treatment, called Rincell-1, given during cochlear implant surgery can improve hearing more than the implant alone. It is for adults whose hearing loss is due to aging (presbycusis) or nerve damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 74 years old (or 60 to 74 for the first group).
- Your hearing loss is caused by aging or nerve damage, not by infection, injury, or medications.
- You qualify for a cochlear implant and can have surgery.
- You have not had a cochlear implant before.
- You are willing to use a specific type of cochlear implant and to receive the cell injection.
- You do not have other serious health conditions or devices that would make the trial unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a regenerative stem cell treatment for people with hearing loss, tinnitus, or inner ear injury. It aims to see if the therapy can improve hearing or reduce symptoms.
This study tests if a cochlear implant fitting based on your ear's anatomy helps you hear speech in noisy places and enjoy music more. It is for people who are deaf in one ear and use a MED-EL cochlear implant.
This trial is studying whether a cochlear implant can help people who have very poor hearing in one ear but normal or mild hearing loss in the other ear. It uses hearing tests and speech understanding to see who may benefit and how well the device works.
This study tests a cochlear implant to help adults with severe hearing loss who don't get enough benefit from hearing aids. The implant may improve hearing and speech understanding.
This trial tests a program to help adults who use a cochlear implant hear better, especially those who have hearing loss in only one ear or who are getting a second implant. It aims to optimize hearing performance after the implant is activated.
This trial tests new sound-processing software in cochlear implants to help users hear speech better in noisy places. It may help adult implant users who struggle with conversations in background noise.
Hear when a new Presbyacusis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.